What is NDC 71610-617?

71610-617 is the product NDC for Carisoprodol, Carisoprodol 350 mg/1 tablet, listed with the FDA by Aphena Pharma Solutions - Tennessee, LLC. It has 4 package NDCs, shown above in 10- and 11-digit form.

Aphena Pharma Solutions - Tennessee, LLC, NDC labeler code 71610. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Carisoprodol?

46 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Carisoprodol NDC 71610-617 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)71610-617Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71610-0617Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
71610-617-30	7161006173071610061730	30 TABLET in 1 BOTTLE, PLASTIC (71610-617-30)Marketed from Nov 24, 2021
71610-617-53	7161006175371610061753	60 TABLET in 1 BOTTLE, PLASTIC (71610-617-53)Marketed from Nov 24, 2021
71610-617-60	7161006176071610061760	90 TABLET in 1 BOTTLE, PLASTIC (71610-617-60)Marketed from Nov 24, 2021
71610-617-70	7161006177071610061770	120 TABLET in 1 BOTTLE, PLASTIC (71610-617-70)Marketed from Nov 24, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Carisoprodol
Generic name (nonproprietary): carisoprodol
Active ingredients: Carisoprodol — 350 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Aphena Pharma Solutions - Tennessee, LLCNDC labeler code 71610
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 040188
Marketing start: Jan 20, 2020
Listing expires: Dec 31, 2026
DEA schedule: CIV
Other FDA classes: Centrally-mediated Muscle Relaxation (Physiologic effect)
Identifiers: Product ID 71610-617_71d51e86-d125-48bc-8c1a-0f08ed9d547eSPL ID 71d51e86-d125-48bc-8c1a-0f08ed9d547eSPL set ID 2179f18b-df15-4bf6-a7c7-6d9960f49a42RxCUI 197446UNII 21925K482H
Pharmacologic class: Muscle Relaxant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471610061730 followed by a unit qualifier and the quantity

Package 71610-0617-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 13, 2021.

Indications (excerpt from the label)

Carisoprodol is indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults. Limitation of Use Carisoprodol should only be used for short periods (up to two or three weeks) because adequate evidence of effectiveness for more prolonged use has not been established and because acute, painful musculoskeletal conditions are generally of short duration. [ see Dosage and Administration (2) ]. Carisoprodol is a muscle relaxant indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults. (1) Limitations of Use Should only be used for acute treatment periods up to two or three weeks ( 1 )…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 71610-617

What is NDC 71610-617?: 71610-617 is the product NDC for Carisoprodol, Carisoprodol 350 mg/1 tablet, listed with the FDA by Aphena Pharma Solutions - Tennessee, LLC. It has 4 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Carisoprodol.
What is the active ingredient?: Carisoprodol.
Who is the labeler?: Aphena Pharma Solutions - Tennessee, LLC, NDC labeler code 71610. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Carisoprodol?: 46 other product NDCs are listed under this name. See all Carisoprodol NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Carisoprodol NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Carisoprodol	Carisoprodol 350 mg/1	TabletOral	St. Mary's Medical Park Pharmacy	60760-397	60760-0397-90
Carisoprodol	Carisoprodol 250 mg/1	TabletOral	Westminster Pharmaceuticals, LLC	69367-419	69367-0419-01
Carisoprodol	Carisoprodol 350 mg/1	TabletOral	Westminster Pharmaceuticals, LLC	69367-420	69367-0420-0169367-0420-05
Carisoprodol	Carisoprodol 350 mg/1	TabletOral	Northwind Health Company, LLC	82868-062	82868-0062-30
carisoprodol	Carisoprodol 350 mg/1	TabletOral	REMEDYREPACK INC.	70518-3792	70518-3792-00
Carisoprodol	Carisoprodol 350 mg/1	TabletOral	Advanced Rx Pharmacy of Tennessee, LLC	80425-0291	80425-0291-0180425-0291-0280425-0291-03
Carisoprodol	Carisoprodol 350 mg/1	TabletOral	Direct_Rx	72189-386	72189-0386-3072189-0386-7272189-0386-90
Carisoprodol	Carisoprodol 350 mg/1	TabletOral	Directrx	72189-310	72189-0310-3072189-0310-6072189-0310-72+1 more
Carisoprodol	Carisoprodol 350 mg/1	TabletOral	REMEDYREPACK INC.	70518-2800	70518-2800-00
Carisoprodol	Carisoprodol 350 mg/1	TabletOral	Medsource Pharmaceuticals	45865-233	45865-0233-3045865-0233-60

All 47 Carisoprodol NDCs

Other NDCs under ANDA 040188

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 040188
Product	Strength	Form · route	Labeler	Product NDC
Carisoprodol	Carisoprodol 350 mg/1	TabletOral	Directrx	72189-310
Carisoprodol	Carisoprodol 350 mg/1	TabletOral	A-S Medication Solutions	50090-5953
Carisoprodol	Carisoprodol 350 mg/1	TabletOral	A-S Medication Solutions	50090-5955
Carisoprodol	Carisoprodol 350 mg/1	TabletOral	Oxford Pharmaceuticals, LLC	69584-111
Carisoprodol	Carisoprodol 350 mg/1	TabletOral	PD-Rx Pharmaceuticals, Inc.	72789-182
Carisoprodol	Carisoprodol 350 mg/1	TabletOral	PD-Rx Pharmaceuticals, Inc.	72789-190
Carisoprodol	Carisoprodol 350 mg/1	TabletOral	Aphena Pharma Solutions - Tennessee, LLC	71610-761
Carisoprodol	Carisoprodol 350 mg/1	TabletOral	Bryant Ranch Prepack	63629-2416
Carisoprodol	Carisoprodol 350 mg/1	TabletOral	Proficient Rx LP	71205-704
Carisoprodol	Carisoprodol 350 mg/1	TabletOral	Bryant Ranch Prepack	72162-1928
Carisoprodol	Carisoprodol 350 mg/1	TabletOral	Bryant Ranch Prepack	71335-9621
Carisoprodol	Carisoprodol 350 mg/1	TabletOral	Medsource Pharmaceuticals	45865-233
Carisoprodol	Carisoprodol 350 mg/1	TabletOral	REMEDYREPACK INC.	70518-2800